Zhu M, Ma Y, Tan K, Zhang L, Wang Z, Li Y
BMC Immunol. 2020; 21(1):19.
PMID: 32299357
PMC: 7164359.
DOI: 10.1186/s12865-020-00352-1.
Mall J, Schwenk W, Philipp A, Buttemeyer R, Pollmann C
World J Surg. 2003; 27(10):1119-23.
PMID: 12947492
DOI: 10.1007/s00268-003-7009-5.
Amato R
Curr Oncol Rep. 2001; 4(1):56-62.
PMID: 11734114
DOI: 10.1007/s11912-002-0048-5.
Neubert R, Nogueira A, Neubert D
Arch Toxicol. 1993; 67(1):1-17.
PMID: 8452474
DOI: 10.1007/BF02072029.
Coulson A, Summers L, Inman D
Br Med J. 1969; 3(5661):52.
PMID: 5815119
PMC: 1983836.
DOI: 10.1136/bmj.3.5661.52.
The effect of two soluble thalidomide derivatives on lymphocyte stimulation.
Coulson A, Summers L, Lindahl-Kiessling K, Tucker D, Hellmann K
Clin Exp Immunol. 1970; 7(2):241-7.
PMID: 5477933
PMC: 1712827.
Tumour host relationships.
Anderson M, Green H
Br J Cancer. 1967; 21(1):27-32.
PMID: 5337450
PMC: 2008072.
DOI: 10.1038/bjc.1967.4.
Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug.
Bonmassar E, Bonmassar A, VADLAMUDI S, Goldin A
Proc Natl Acad Sci U S A. 1970; 66(4):1089-95.
PMID: 5273445
PMC: 335790.
DOI: 10.1073/pnas.66.4.1089.
Prolonged survival of glutaraldehyde-treated skin homografts.
Schechter I
Proc Natl Acad Sci U S A. 1971; 68(7):1590-3.
PMID: 4934523
PMC: 389247.
DOI: 10.1073/pnas.68.7.1590.
[Immunosuppression by cyclic imides in the rat].
Ellenrieder M, Frankus E, KRUPE W
Klin Wochenschr. 1967; 45(22):1159-60.
PMID: 4874023
DOI: 10.1007/BF01727401.
Effect of ribonucleic acid perfusion on canine kidney and liver homograft survival.
Groth C, Porter K, Daloze P, Huguet C, Smith G, BRETTSCHNEIDER L
Surgery. 1968; 64(1):31-8.
PMID: 4872766
PMC: 2958524.
Treatment of Behçet's disease with thalidomide.
Hamza M
Clin Rheumatol. 1986; 5(3):365-71.
PMID: 3780143
DOI: 10.1007/BF02054255.
The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information.
WOOD P, Proctor S
Leuk Res. 1990; 14(5):395-9.
PMID: 2189044
PMC: 7133718.
DOI: 10.1016/0145-2126(90)90024-4.
Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.
Gunzler V
Drug Saf. 1992; 7(2):116-34.
PMID: 1605898
DOI: 10.2165/00002018-199207020-00004.
